Holen Sie sich die Stockscreener-App
6.40
1.08%
-0.07
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Finanzdaten der Gyre Therapeutics Inc-Aktie (GYRE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
29.25%
29.11
|
22.52 | 37.20 | 30.56 | 26.77 |
| Cost Of Revenue |
80.03%
2.209
|
1.227 | 1.743 | 1.628 | 1.151 |
| Operating Expenses |
36.36%
43.46
|
31.87 | 40.75 | 22.01 | 23.45 |
| Costs And Expenses |
36.37%
43.47
|
31.87 | 37.08 | 23.64 | 24.60 |
| Operating Income/Loss |
53.53%
-14.36
|
-9.355 | 0.118 | 6.925 | 2.171 |
| Net Interest Income/Expense |
0.74
|
- | - | - | - |
| Income/Loss From Continuing Operations Before Tax |
56.26%
-14.43
|
-9.237 | -0.066 | 7.629 | 2.238 |
| Income Tax Expense/Benefit |
126.41%
-0.164
|
0.621 | 1.30 | 1.693 | 0.662 |
| Income/Loss From Continuing Operations After Tax |
44.76%
-14.27
|
-9.858 | -1.366 | 5.936 | 1.576 |
Net Income/Loss
|
44.76%
-14.27
|
-9.858 | -1.366 | 5.936 | 1.576 |
| Attributable To Noncontrolling Interest |
214.05%
-3.665
|
-1.167 | 0.357 | 2.326 | 1.134 |
| Basic Average Shares |
10.21%
100.64
|
91.32 | - | 90.85 | 89.12 |
| Diluted Average Shares |
10.17%
100.64
|
91.34 | - | 103.97 | 102.70 |
| Basic Earnings Per Share |
20.00%
-0.12
|
-0.10 | - | 0.04 | - |
| Diluted Earnings Per Share |
20.00%
-0.12
|
-0.10 | - | 0.03 | - |
0.10%
3.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):